Copyright
©The Author(s) 2026.
World J Orthop. Feb 18, 2026; 17(2): 112757
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.112757
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.112757
Figure 1 Distribution of the administered low-molecular-weight heparin among the early prosthetic joint infection cases in each group.
PJI: Prosthetic joint infection.
- Citation: Nageeb Mahmoud AM, Maniar HH, Bernate J, Horwitz DS. Weight-adjusted low molecular weight heparin with surgery morning dose administration: Impact on hip hemiarthroplasty early infections. World J Orthop 2026; 17(2): 112757
- URL: https://www.wjgnet.com/2218-5836/full/v17/i2/112757.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i2.112757
